Magnesium sulfate tocolysis: Time to quit

Obstetrics and Gynecology

Volumn 108, Issue 4, 2006, Pages 986-989

  Grimes, David A ^a   Nanda, Kavita ^a  

^a FAMILY HEALTH INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CALCIUM CHANNEL BLOCKING AGENT; GLUCOSE; MAGNESIUM SULFATE; NIFEDIPINE; PLACEBO; UTERUS SPASMOLYTIC AGENT;

CHILDHOOD MORTALITY; CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DELIVERY; DRUG APPROVAL; DRUG EFFICACY; DRUG FATALITY; FOLLOW UP; HUMAN; HYDRATION; INTRAVENOUS ADMINISTRATION; MEDICAL ETHICS; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SEDATION; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; TOCOLYSIS; UNITED STATES;

BIOMEDICAL RESEARCH; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MAGNESIUM SULFATE; OBSTETRIC LABOR, PREMATURE; ORGANIZATIONAL POLICY; PREGNANCY; PREGNANCY OUTCOME; RANDOMIZED CONTROLLED TRIALS; SOCIETIES, MEDICAL; TOCOLYTIC AGENTS;

EID: 33749346346     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000236445.18265.93     Document Type: Review

References (10)

1. Mittendorf R, Pryde P, Khoshnood B, Lee KS. If tocolytic magnesium sulfate is associated with excess total pediatric mortality, what is its impact? Obstet Gynecol 1998;92:308-11.
2. Mittendorf R, Pryde PG. A review of the role for magnesium sulphate in preterm labour. BJOG 2005;112 suppl:84-8.
3. Elliott JP. Magnesium sulfate as a tocolytic agent. Am J Obstet Gynecol 1983;147:277-84.
4. Norwitz ER, Robinson JN, Challis JR. The control of labor. N Engl J Med 1999;341:660-6.
5. Crowther CA, Hiller JE, Doyle LW. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database Syst Rev 2002;CD001060.
6. Gyetvai K, Hannah ME, Hodnett ED, Ohlsson A. Tocolytics for preterm labor: a systematic review. Obstet Gynecol 1999;94:869-77.
7. Mittendorf R, Covert R, Boman J, Khoshnood B, Lee KS, Siegler M. Is tocolytic magnesium sulphate associated with increased total paediatric mortality? Lancet 1997;350:1517-8.
8. Cox SM, Sherman ML, Leveno KJ. Randomized investigation of magnesium sulfate for prevention of preterm birth. Am J Obstet Gynecol 1990;163:767-72.
9. Scudiero R, Khoshnood B, Pryde PG, Lee KS, Wall S, Mittendorf R. Perinatal death and tocolytic magnesium sulfate. Obstet Gynecol 2000;96:178-82.
10. Crowther CA, Hiller JE, Doyle LW, Haslam RR, Australasian Collaborative Trial of Magnesium Sulphate (ACTOMg SO4) Collaborative Group. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. JAMA 2003;290:2669-76.